Alan B Lancz & Associates, Inc.: GSK position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Alan B Lancz & Associates, Inc. on GSK, newest first. How the timeline and the estimate are built.
Alan B Lancz & Associates, Inc. held 8,750 GSK shares at 2026-06-30 per its 13F-HR filed 2026-08-11.
the latest 13F is the newest step
- period ended2026-06-3013F 8,750 sharesChange vs previous 13F 0 shares
0.4% of the 13F portfolio, value $458,675.
13F-HR 0001765380-26-000339 filed by Alan B Lancz & Associates, Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 8,750 sharesChange vs previous 13F -870 shares
0.47% of the 13F portfolio, value $482,913.
13F-HR 0001765380-26-000154 filed by Alan B Lancz & Associates, Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 9,620 sharesChange vs previous 13F 0 shares
0.41% of the 13F portfolio, value $471,765.
13F-HR 0001897835-26-000001 filed by Alan B Lancz & Associates, Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 9,620 sharesChange vs previous 13F -160 shares
0.38% of the 13F portfolio, value $415,200.
13F-HR 0001765380-25-000497 filed by Alan B Lancz & Associates, Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 9,780 sharesChange vs previous 13F -720 shares
0.38% of the 13F portfolio, value $375,552.
13F-HR 0001897835-25-000003 filed by Alan B Lancz & Associates, Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 10,500 sharesChange vs previous 13F -120 shares
0.43% of the 13F portfolio, value $406,770.
13F-HR 0001897835-25-000002 filed by Alan B Lancz & Associates, Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 10,620 sharesChange vs previous 13F -280 shares
0.36% of the 13F portfolio, value $359,169.
13F-HR 0001897835-25-000001 filed by Alan B Lancz & Associates, Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 10,900 sharesChange vs previous 13F not available
0.41% of the 13F portfolio, value $445,592.
13F-HR 0001897835-24-000003 filed by Alan B Lancz & Associates, Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).